VIR Mar 2025 7.500 put
| Previous Close | 0.8500 |
| Open | 1.0600 |
| Bid | 0.0000 |
| Ask | 1.9500 |
| Strike | 7.50 |
| Expire Date | 2025-03-21 |
| Day's Range | 0.8500 - 1.0600 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 49 |
Business WireVir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024
SAN FRANCISCO, October 17, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2024, on October 31, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on October 31, 2024.
Business WireVir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD’s The Liver Meeting® 2024
SAN FRANCISCO, October 15, 2024--Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of tobevibart, an investigational monoclonal antibody (mAb), and elebsiran, an investigational small interfering ribonucleic acid (siRNA) for the potential treatment of chronic hepatitis delta.
Simply Wall St.Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company
Key Insights Significantly high institutional ownership implies Vir Biotechnology's stock price is sensitive to their...
